Boda Zhou

818 total citations
44 papers, 554 citations indexed

About

Boda Zhou is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Boda Zhou has authored 44 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 17 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Boda Zhou's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Coronary Interventions and Diagnostics (4 papers) and Cardiovascular Disease and Adiposity (3 papers). Boda Zhou is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Coronary Interventions and Diagnostics (4 papers) and Cardiovascular Disease and Adiposity (3 papers). Boda Zhou collaborates with scholars based in China, Romania and Australia. Boda Zhou's co-authors include Lingfang Zeng, Qingbo Xu, Wei Gao, Lingyun Zu, Andriani Margariti, Lemin Zheng, Ping Zhang, Qingzhong Xiao, Yanhua Hu and Daniel Martin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Boda Zhou

34 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boda Zhou China 13 324 89 88 62 52 44 554
Nermin Ali Japan 13 278 0.9× 82 0.9× 45 0.5× 47 0.8× 76 1.5× 18 506
Jingti Deng China 16 434 1.3× 157 1.8× 98 1.1× 84 1.4× 82 1.6× 31 767
Yuanzhou He China 15 300 0.9× 164 1.8× 36 0.4× 55 0.9× 46 0.9× 31 608
Masamichi Nogi Japan 14 245 0.8× 90 1.0× 178 2.0× 46 0.7× 83 1.6× 16 586
Shiqun Sun China 13 288 0.9× 78 0.9× 104 1.2× 44 0.7× 46 0.9× 34 559
Yisong Zhen China 16 282 0.9× 39 0.4× 212 2.4× 37 0.6× 65 1.3× 27 647
Jutta Meyer-Kirchrath Germany 15 211 0.7× 63 0.7× 146 1.7× 38 0.6× 52 1.0× 24 652
Weili Xue China 12 282 0.9× 122 1.4× 51 0.6× 99 1.6× 42 0.8× 23 557
Yoshiki Higashijima Japan 14 362 1.1× 69 0.8× 46 0.5× 71 1.1× 113 2.2× 24 729

Countries citing papers authored by Boda Zhou

Since Specialization
Citations

This map shows the geographic impact of Boda Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boda Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boda Zhou more than expected).

Fields of papers citing papers by Boda Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boda Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boda Zhou. The network helps show where Boda Zhou may publish in the future.

Co-authorship network of co-authors of Boda Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Boda Zhou. A scholar is included among the top collaborators of Boda Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boda Zhou. Boda Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fan, Hongxuan & Boda Zhou. (2025). Aspirin’s echo: rebound, delay, or statistical mirage? Re-examining legacy cardiovascular risk after cessation. European Heart Journal. 47(2). 273–273. 1 indexed citations
3.
Wang, Yumeng, et al.. (2025). Farnesoid X Receptor Agonist in Patients With NAFLD: A Meta-Analysis of Metabolic Benefit and Risk. American Journal of Therapeutics. 32(4). e364–e368.
4.
Liu, Fang, et al.. (2025). Case Report: Painful left bundle branch block syndrome complicated with vasovagal syncope. Frontiers in Cardiovascular Medicine. 11. 1438320–1438320.
5.
Lai, Wei-Cheng, Lei Wang, Yingying Wu, et al.. (2025). Association between metabolic score for insulin resistance and hypertension in middle-aged and older adults: a nationwide cross-sectional and longitudinal study. Aging Clinical and Experimental Research. 37(1). 187–187.
6.
Fang, Fang, et al.. (2025). Prediction of mortality in intensive care unit with short-term heart rate variability: Machine learning-based analysis of the MIMIC-III database. Computers in Biology and Medicine. 186. 109635–109635. 1 indexed citations
7.
Wang, Lei, et al.. (2025). Association between TG/HDL-C and hypertension in Chinese middle-aged and older adults: findings from CHARLS. BMC Cardiovascular Disorders. 25(1). 254–254. 2 indexed citations
8.
Chen, Xudong, Chang Liu, Xiangmei Chen, et al.. (2024). Structural basis for the reaction cycle and transport mechanism of human Na + -sulfate cotransporter NaS1 (SLC13A1). Science Advances. 10(47). eado6778–eado6778.
9.
10.
Zhou, Boda, et al.. (2024). Recurrent ventricular arrhythmias and heart failure induced by osimertinib- a case report. Frontiers in Cardiovascular Medicine. 11. 1423647–1423647. 2 indexed citations
11.
Lu, Yonghao, Fang Fang, Xuegong Zhang, et al.. (2023). The prognostic value of intraoperative HRV during anesthesia in patients presenting for non-cardiac surgery. BMC Anesthesiology. 23(1). 160–160. 5 indexed citations
12.
Li, Siyuan, Yifang Yuan, Fei She, et al.. (2022). Coronary stenosis is a risk marker for impaired cardiac function on cardiopulmonary exercise test. BMC Cardiovascular Disorders. 22(1). 486–486. 4 indexed citations
13.
Li, Yanbing, Yu Geng, Boda Zhou, et al.. (2021). Long Non-coding RNA GAS5 Worsens Coronary Atherosclerosis Through MicroRNA-194-3p/TXNIP Axis. Molecular Neurobiology. 58(7). 3198–3207. 16 indexed citations
14.
Guo, Jun, Boda Zhou, Yifang Yuan, et al.. (2020). CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study. Epidemiology and Infection. 148. e241–e241. 46 indexed citations
15.
Zhou, Boda, Weimin Wang, Ou Zhang, et al.. (2019). An application of RASER technique in the treatment of chronic total occlusion accompanied with stent fracture in right coronary artery: a case report. BMC Cardiovascular Disorders. 19(1). 273–273. 2 indexed citations
16.
Zhou, Boda, Lingyun Zu, Yong Chen, et al.. (2017). Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration. Lipids in Health and Disease. 16(1). 3–3. 20 indexed citations
17.
Zhang, Xinlu, Boda Zhou, Haibin Chen, et al.. (2016). A novel hydrodynamic approach of drag-reducing polymers to improve left ventricular hypertrophy and aortic remodeling in spontaneously hypertensive rats. International Journal of Nanomedicine. Volume 11. 6743–6751. 5 indexed citations
18.
Zhou, Boda, Jizhao Li, Shaomin Chen, et al.. (2016). Time course of various cell origin circulating microparticles in ST-segment elevation myocardial infarction patients undergoing percutaneous transluminal coronary intervention. Experimental and Therapeutic Medicine. 11(4). 1481–1486. 10 indexed citations
19.
Zu, Lingyun, Chuan Ren, Bing Pan, et al.. (2015). Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells. International Journal of Cardiology. 202. 756–759. 21 indexed citations
20.
Zhou, Boda, Andriani Margariti, Lingfang Zeng, & Qingbo Xu. (2011). Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovascular Research. 90(3). 413–420. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nermin Ali Breakdown of academic impact, for papers by Jingti Deng Breakdown of academic impact, for papers by Yuanzhou He Breakdown of academic impact, for papers by Masamichi Nogi Breakdown of academic impact, for papers by Shiqun Sun Breakdown of academic impact, for papers by Yisong Zhen Breakdown of academic impact, for papers by Jutta Meyer-Kirchrath Breakdown of academic impact, for papers by Weili Xue Breakdown of academic impact, for papers by Yoshiki Higashijima
Rankless by CCL
2026